Cargando…
Exploring Novel Therapeutic Approaches for Depressive Disorders: The Role of Allopregnanolone Agonists
Depressive disorders are caused due to the impaired functioning of important brain networks. Recent studies have also shown that it is caused by a significant reduction in the levels of allopregnanolone, which is a progesterone metabolite. Newer treatment modalities are now focusing on the usage of...
Autores principales: | Bhatti, Najeeha Ahmad, Jobilal, Anna, Asif, Kainat, Jaramillo Villegas, Mateo, Pandey, Priyanka, Tahir, Ayzal Noor, Balla, Neeharika, Arellano Camargo, Maryoreht Paola, Ahmad, Sana, Kataria, Janvi, Abdin, Zain U, Ayyan, Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517642/ https://www.ncbi.nlm.nih.gov/pubmed/37746458 http://dx.doi.org/10.7759/cureus.44038 |
Ejemplares similares
-
Allopregnanolone in Postpartum Depression
por: Pinna, Graziano, et al.
Publicado: (2022) -
Trajectories of Allopregnanolone and Allopregnanolone to Progesterone Ratio across the Six Subphases of Menstrual Cycle
por: Hamidovic, Ajna, et al.
Publicado: (2023) -
Allopregnanolone and neurogenesis in the nigrostriatal tract
por: Wang, Jun Ming
Publicado: (2014) -
Neuroregenerative Mechanisms of Allopregnanolone in Alzheimer’s Disease
por: Irwin, Ronald W., et al.
Publicado: (2012) -
Biosynthesis and biological action of pineal allopregnanolone
por: Tsutsui, Kazuyoshi, et al.
Publicado: (2014)